University of Maryland at Baltimore
Which Interventions for COPD are Most Cost-Effective?
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. The chronic condition is associated with a substantial health and economic burden on society. To reduce the burden of COPD, researchers have attempted to design new medical and policy interventions. However, these interventions come at a cost, and it is not known whether they produce value for the resources they consume. We will develop a national simulation model of COPD to quantify the natural history of disease progression, as well as lifetime health and costs of COPD patients in the U.S. We will measure and compare health and economic benefits of a variety of different medical (including medications and pulmonary rehabilitation) and policy (including smoking cessation policies) interventions to see which of them would produce the highest value for society.